On this page
What each program costs in Ohio
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
Does the State of Ohio employee health plan (Ohio DAS) cover GLP-1s for weight loss?
Ohio's state employee benefits plan stopped covering GLP-1s for weight loss, such as Wegovy and Zepbound, on July 1, 2025. GLP-1s for diabetes, such as Ozempic and Mounjaro, stay covered.
Ohio Department of Administrative Services
The Department of Administrative Services says weight-loss GLP-1s are no longer covered from July 1, 2025.
“GLP-1 medications for weight loss, such as Wegovy, Zepbound, Saxenda, etc., are no longer covered by the state’s benefits plan effective July 1, 2025.”
https://das.ohio.gov/employee-relations/benefits-administration/medical/weight-loss-resources · read Oct 29, 2026
Ohio Department of Administrative Services
Diabetes GLP-1s continue to be covered.
“GLP-1 medications for diabetes, such as Ozempic and Mounjaro, will continue to be covered.”
https://das.ohio.gov/employee-relations/benefits-administration/medical/weight-loss-resources · read Oct 29, 2026
Does Ohio Medicaid cover GLP-1s for weight loss?
Wegovy no, Zepbound not confirmed
Ohio Medicaid lists Wegovy only under non-obesity uses, with criteria for heart events and a liver condition, so it does not cover Wegovy for weight loss alone; a state document on Zepbound could not be found. Read from state documents Nov 6, 2026.
What Ohio Medicaid's documents say about each drug for weight loss. Read Nov 6, 2026. Ohio Department of Medicaid.
WegovyNo
Preferred with prior authorization for major adverse cardiovascular events (age 18 or older, BMI of 27 or higher, history of heart attack, stroke or artery disease) or MASH. Not authorized for patients with type 1 or type 2 diabetes.
“Glucagon-Like Peptide-1 (GLP-1) Agonists for Non-Obesity Indications”
Ohio Department of Medicaid, Unified Preferred Drug List · Effective Oct 1, 2026 · read Nov 6, 2026
“Initial review for diagnosis of Major Adverse Cardiovascular Events (MACE)”
Ohio Department of Medicaid, Unified Preferred Drug List · Effective Oct 1, 2026 · read Nov 6, 2026
“Initial review for diagnosis of Metabolic Dysfunction-Associated Steatohepatitis (MASH)”
Ohio Department of Medicaid, Unified Preferred Drug List · Effective Oct 1, 2026 · read Nov 6, 2026
ZepboundNot confirmed
The October 2026 Unified Preferred Drug List does not mention Zepbound, and absence is not a no. No state document naming Zepbound's coverage was found. The only mention read is a safety note in a 2026 DUR digest.
OzempicUnclear
The October 2026 list places Ozempic as non-preferred in the diabetes class, with criteria built on A1C goals, but it does not state a required diagnosis or a weight-loss exclusion. A state pharmacy portal page reportedly says weight loss is not covered, but it could not be opened, so it is only a lead.
MounjaroNo
Non-preferred in the diabetes class. Requires A1C above 7 percent before starting and a trial of Ozempic or a documented reason it cannot be used.
“Additional Mounjaro (tirzepatide) Criteria: • Prior to initiation, must have hemoglobin A1C > 7% AND”
Ohio Department of Medicaid, Unified Preferred Drug List · Effective Oct 1, 2026 · read Nov 6, 2026
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Ohio Department of Medicaid documents. KFF's January 2026 map listed this program as not covered; the documents we read answer only part of the question.
Weight loss
Not covered in part, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
10,834 prescriptions
Ozempic and Mounjaro, 2025
42,735 prescriptions
Neighbours covering weight loss
1 of 5
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Ohio Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Ohio Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Ohio Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Ohio Medicaid pay for?
425,143 GLP-1 prescriptions in 2025, 6th of the 50 states and DC, with $400.5 million reimbursed before rebates. Counting the share other payers covered, $406.8 million.
Prescriptions, 2025
425,143
6th of 51
Medicaid paid
$400.5M
6th of 51, before rebates
Per prescription
$942
$1,051 nationally
Weight-loss brands
2.5%
31st highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Ohio is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 2.5% of Ohio Medicaid's GLP-1 prescriptions in 2025 (10,834). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Trulicity was Ohio Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Trulicity | 359,093 | 84% | $341.0 million | $950 |
| Mounjaro | 25,193 | 5.9% | $23.6 million | $938 |
| Ozempic | 17,542 | 4.1% | $15.0 million | $855 |
| Wegovyapproved for weight management | 7,780 | 1.8% | $10.1 million | $1,304 |
| Victoza | 6,622 | 1.6% | $4.1 million | $625 |
| Liraglutide (generic) | 4,292 | 1.0% | $2.0 million | $461 |
| Zepboundapproved for weight management | 2,992 | 0.7% | $3.2 million | $1,058 |
| Rybelsus | 1,197 | 0.3% | $1.1 million | $901 |
| Byetta | 255 | 0.1% | $209,568 | $822 |
| Exenatide (generic) | 89 | 0.0% | $66,770 | $750 |
| Saxendaapproved for weight management | 62 | 0.0% | $72,944 | $1,177 |
| Bydureon | 26 | 0.0% | $20,903 | $804 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Ohio?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 3 in Ohio. The register does not say which, if any, supplies a program on this page.
- RC Outsourcing, LLC, Lowellville. Registered since Oct 7, 2015; last FDA inspection Sep 3, 2026.
- STAQ Pharma of Ohio, LLC, Columbus. Registered since Jan 26, 2023; last FDA inspection Aug 19, 2026.
- Wedgewood Connect Ohio, LLC, Albany. Registered since Oct 19, 2023; not yet inspected by FDA.
On Medicare in Ohio?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Ohio and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
1 of the 5 states next to Ohio covers GLP-1s for weight loss through Medicaid: Michigan. None has a lower cash floor than Ohio's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Ohio | Not covered in part | 19 | $39/mo |
| Indiana | Not covered | 19 | $39/moWellmedr |
| Kentucky | Not covered | 19 | $39/moWellmedr |
| Michigan | Covered | 19 | $39/moWellmedr |
| Pennsylvania | Not covered | 19 | $39/moWellmedr |
| West Virginia | Not covered | 18 | $39/moWellmedr |






















